joint Meeting Timetable

Thursday, September 19, 2024
Hall A
IACH + COLYM
Hall B
COMydAL + MPNCo&D
08:30-09:00 Welcome Coffee
09:00-12:00 Transplant Workshop
12:00-12:45 Lunch Break
12:45-13:00 Joint Meeting Opening Message
13:00-14:30 Session 1a:
Indolent lymphoma
Session 1b:
Controversies in lower risk MDS
14:30-15:30 Industry Symposium Industry Symposium
15:30-16:00 Coffee Break
16:00-17:30 Session 2a:
Hodgkin lymphoma
Session 2b
17:30-18:30 Industry Symposium
Industry Symposium
18:30-18:45 Technical Break
18:45-20:15 Session 3a:
Diffuse large B cell lymphoma (DLBCL)
Session 3b:
Controversies in higher risk MDS
20:15 Meeting Welcome Reception
Friday, September 20, 2024
Hall A
IACH + COLYM
Hall B
COMydAL + MPNCo&D
07:30-08:00 Welcome Coffee
08:00-09:00 IACH Plenary Lectures
09:00-09:15 Short Coffee Break
09:15-10:45 Industry Symposium
Industry Symposium
10:45-11:00 Technical Break
11:00-12:30 Session 4a:
T cell non-Hodgkin lymphoma (T-NHL)
Session 4b
12:30-13:45 Lunch Break
13:45-14:45 Industry Symposium
Industry Symposium
14:45-15:00 Technical Break
15:00-17:00 Session 5a:
Chronic lymphocytic leukemia (CLL)
Session 5b:
Controversies in classification, risk stratification and response assessment in AML
17:00-17:15 Short Coffee Break
17:15-18:45 Session 6a:
Minimal residual disease (MRD)

Session 6b
18:45-19:15 IACH Awards
Saturday, September 21, 2024
Hall A
IACH + COLYM
Hall B
COMydAL + MPNCo&D
07:30-08:00 Welcome Coffee
08:00-09:30 Session 7a:
Mantle cell lymphoma (MCL)
Session 7b:
Controversies in the management of AML
09:30-11:00 Industry Symposium Industry Symposium
11:00-11:30 Coffee Break
11:30-13:00 Session 8a:
Rare diseases
Session 8b
13:00-13:45 Lunch Break
13:45-14:45 Industry Symposium
Industry Symposium
14:45-15:00 Technical Break
15:00-17:00 IACH Plenary Lectures
17:00-17:15 Joint Meeting Closing Remarks